Clinical trials depend on the ability to connect the right patients with the right studies. Yet across the research industry, identifying eligible participants is becoming increasingly complex.
That’s why improving patient access to clinical trials is a top priority for clinical research sites like Remington-Davis. Partnerships with community-based healthcare networks help us meet this goal.
Clinical trial enrollment always required careful planning. Today, multiple factors are making it that much harder to identify and retain qualified participants.
One major challenge is increasing protocol complexity. As the clinical trial process incorporates more endpoints, procedures, and monitoring requirements, eligibility criteria often become narrower. While these requirements can improve data quality, they also significantly reduce the number of patients who qualify for participation.
At the same time, logistical and financial barriers can prevent otherwise eligible participants from enrolling. Transportation challenges, demanding visit schedules, and the need to take time away from work or family responsibilities can make participation difficult. These burdens affect patient enrollment outcomes and contribute to participant dropout during the study.
To this end, expanding access begins with designing trials that are practical for patients.
At RDI, we work closely with sponsors and CROs during study startup to provide feedback on protocol feasibility. Our team also reduces patient participation barriers by offering:
These operational strategies help ensure that once patients are identified, they can realistically take part in and remain engaged throughout the study.
However, even when logistical barriers are addressed in accessing clinical trials, another major challenge remains. Many patients simply don’t know clinical trials exist.
A significant portion of the population is unfamiliar with how trials work, how to find them, or whether they might qualify. So, beyond operational support, increasing patient access to clinical trials requires education, ideally in the context of trusted healthcare relationships.
When clinical research sites operate within a broader healthcare network, they have access to patient populations that might otherwise remain unaware of research opportunities. These relationships allow physicians to introduce relevant clinical trials during routine care visits — at the exact moment when patients may be exploring treatment options.
Just as importantly, these recommendations come from healthcare providers that patients already know and trust.
For many individuals, clinical research can feel unfamiliar or intimidating. But when a trusted primary care physician or specialist explains a trial and its potential benefits, patients are often far more open to learning more.
This model can be particularly effective for trials involving:
By integrating research opportunities into everyday healthcare settings, community-based networks bridge the gap between clinical care and clinical research, making trials more accessible and approachable for patients.
Healthcare partnerships are only one piece of the equation. Expanding patient access to clinical trials means sites must also engage directly with the communities they serve.
At RDI, community outreach is central to our recruitment strategy. Our team regularly participates in initiatives designed to educate individuals about clinical research and the opportunities available to them.
These efforts include:
These boots-on-the-ground initiatives demystify clinical research by giving people the opportunity to ask questions, better understand how trials work, and learn how clinical trial participation contributes to medical progress. Over time, this type of education-centered outreach cultivates awareness and trust.
When patients realize that research opportunities exist within their own community, they’re far more likely to consider participation.
As clinical trials become more complex and patient recruitment grows more competitive, sites must take an increasingly proactive role in ensuring studies reach the populations they need.
At Remington-Davis, we combine community-based healthcare partnerships, patient-centered operational support, and local outreach and education initiatives to help sponsors and CROs connect with engaged, qualified participants.
By strengthening patient access to clinical trials at every level — from protocol feasibility to community engagement — we keep studies on track and deliver the high-quality data sponsors depend on.
Interested in working with a site that prioritizes patient access and engagement? Contact Remington-Davis to learn how we can support your next clinical trial and bring novel therapies to market faster.
Many patients are not aware that clinical trials are an option for their condition. Research opportunities are often disconnected from the healthcare settings where patients receive routine care, making them harder to discover. Improving awareness and integrating research into healthcare networks can help close this gap.
Healthcare systems can improve access by incorporating clinical trial opportunities into routine patient care. When providers are aware of active studies, they can introduce relevant trials during consultations with eligible patients. Integrating research referrals into clinical workflows helps connect patients with studies earlier in their care journey.
Many patients never enroll in clinical trials due to limited knowledge, misconceptions, and concerns about financial burdens and time commitments. Providing clear, accessible information helps patients understand the potential benefits, risks, and requirements of participation. Patients often report improved perceptions related to the cost and time associated with participation in clinical trials after receiving education.
Protocol design can significantly influence how easy or difficult it is for patients to participate in a study. Frequent site visits, complex procedures, or restrictive eligibility criteria can reduce the number of patients who qualify or are able to enroll. Early collaboration between sponsors and experienced research sites can help identify opportunities to simplify protocols and improve feasibility.
Clinical trials are voluntary, and patients must balance participation with their daily responsibilities. When trials are designed with patient convenience in mind, more patients are more likely to enroll and remain engaged throughout the study. This patient-centric approach improves both enrollment and retention outcomes.